Society and mental health
MORE SPEAKERSAgnieszka Leszczyńska
General Director, President of the Board, Angelini Pharma Poland
General Director, President of the Board, Angelini Pharma Poland
Agnieszka Leszczyńska has been working for Angelini Pharma, the international pharmaceutical division of Angelini Industries, for the past ten years, and has been leading the company’s business operations in Poland for four years. She has many years of experience in managing complex brand portfolios in the pharmaceutical sector. Her managerial career in the industry began at Polfarmex S.A., where she was in charge of OTC marketing and sales. Before that, at Pernod Ricard Wyborowa S.A., she was responsible for the marketing activities associated with the company’s flagship brand, Wyborowa, in several dozen export markets.
In her approach to business, she relies on cutting-edge technology, her two guiding principles being digitization and efficiency. This translates into the rapid development and high profitability of the business she manages. As she herself admits, she feels most at home in the pharmaceutical industry. It comes as no surprise, then, that Angelini Pharma Polska has become the undisputed leader in Mental Health – as evidenced by prestigious awards for bringing breakthrough treatments to the market – and aspires to become an admired European innovator.
You watching archival version of European Economic Congress
What you can do:
Go to the current edition page or Continue browsing